Viking Global Investors Portfolio holdings
AUM
$34.6B
This Quarter Return
-9.33%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$24.7B
AUM Growth
+$24.7B
(-29%)
Cap. Flow
-$5.25B
Cap. Flow
% of AUM
-21.24%
Top 10 Holdings %
Top 10 Hldgs %
40.01%
Holding
123
New
16
Increased
31
Reduced
30
Closed
31
Top Buys
| 1 |
Mastercard
MA
|
$641M |
| 2 |
Amazon
AMZN
|
$472M |
| 3 |
International Flavors & Fragrances
IFF
|
$432M |
| 4 |
XP
XP
|
$284M |
| 5 |
Otis Worldwide
OTIS
|
$272M |
Top Sells
| 1 |
Humana
HUM
|
$1.24B |
| 2 |
Ginkgo Bioworks
DNA
|
$1.16B |
| 3 |
Twilio
TWLO
|
$785M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
$659M |
| 5 |
GE Aerospace
GE
|
$479M |
Sector Composition
| 1 | Healthcare | 27.58% |
| 2 | Financials | 20.43% |
| 3 | Industrials | 13.4% |
| 4 | Technology | 13.29% |
| 5 | Communication Services | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Procept Biorobotics
PRCT
$2.23B
| $128M | 0.52% | 3,658,892 -1,249,000 | -25% | -$43.7M |
|
52
Booking.com
BKNG
$181B
| $127M | 0.51% | 54,234 -74,044 | -58% | -$174M |
|
|
KRTX
53
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $124M | 0.5% | 974,345 +110,681 | +13% | +$14M |
|
54
Progressive
PGR
$145B
| $118M | 0.48% | +1,037,306 | New | +$118M |
|
|
INBX
55
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $118M | 0.48% | 5,305,866 | – | – |
|
56
PVH
PVH
$4.05B
| $118M | 0.48% | 1,542,375 +773,566 | +101% | +$59.3M |
|
57
Avantor
AVTR
$9.18B
| $117M | 0.47% | 3,459,963 -5,327,379 | -61% | -$180M |
|
|
BHVN
58
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $115M | 0.46% | 966,139 +617,356 | +177% | +$73.2M |
|
59
JD.com
JD
$44.1B
| $101M | 0.41% | 1,748,330 -2,017,591 | -54% | -$117M |
|
60
Perrigo
PRGO
$3.27B
| $97M | 0.39% | +2,525,266 | New | +$97M |
|
61
MetLife
MET
$54.1B
| $95.7M | 0.39% | +1,362,166 | New | +$95.7M |
|
62
Lithia Motors
LAD
$8.63B
| $95.1M | 0.38% | 316,904 -474,180 | -60% | -$142M |
|
63
Zentalis Pharmaceuticals
ZNTL
$122M
| $93.5M | 0.38% | 2,026,656 -91,628 | -4% | -$4.23M |
|
64
Amylyx Pharmaceuticals
AMLX
$836M
| $92.1M | 0.37% | +7,170,536 | New | +$92.1M |
|
65
Take-Two Interactive
TTWO
$43B
| $90.5M | 0.37% | 588,443 -615,518 | -51% | -$94.6M |
|
66
Dollar General
DG
$23.9B
| $86.5M | 0.35% | +388,317 | New | +$86.5M |
|
67
Inspire Medical Systems
INSP
$2.77B
| $79.8M | 0.32% | +310,881 | New | +$79.8M |
|
68
Elevance Health
ELV
$71.8B
| $69.2M | 0.28% | +140,895 | New | +$69.2M |
|
69
Blackstone
BX
$134B
| $64.7M | 0.26% | +509,587 | New | +$64.7M |
|
70
Celldex Therapeutics
CLDX
$1.47B
| $62.9M | 0.25% | 1,846,647 +1,088,766 | +144% | +$37.1M |
|
|
XYZ
71
Block, Inc.
XYZ
$48.5B
| $61.2M | 0.25% | 451,534 -3,413 | -0.8% | -$463K |
|
72
4D Molecular Therapeutics
FDMT
$288M
| $59.5M | 0.24% | 3,937,914 | – | – |
|
73
Boeing
BA
$177B
| $58.5M | 0.24% | +305,347 | New | +$58.5M |
|
74
Pharvaris
PHVS
$1.39B
| $46.4M | 0.19% | 2,480,319 +24,783 | +1% | +$463K |
|
|
FTCH
75
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $42.6M | 0.17% | 2,819,222 -3,126,874 | -53% | -$47.3M |
|